Navigation Links
Research and Markets: Biologics in the Emerging Markets: Ripe for Realization of the Commercial Potential - But Hurdles Still to Overcome
Date:2/21/2013

(PRWEB) February 21, 2013

Research and Markets has announced the addition of the "Biologics in the Emerging Markets: Ripe for Realization of the Commercial Potential - But Hurdles Still to Overcome" report to their offering.

Biologics cover a diverse range of products and deliverables and have revolutionized the treatment of many diseases. The complexity of biologics has made their manufacturing process, an expensive and lengthy process which has hindered uptake in many less developed healthcare markets. However, the global biologics market is rapidly growing and was estimated to be worth over $130 billion in 2010.

Of the emerging markets, the BRIC markets offer the greatest potential for pharmaceutical growth, especially in biologics which represent a relatively untapped market in these countries. It is expected the BRIC markets will account for over 25% of global biologic revenues by 2015.

The report, Biologics in the Emerging Markets: Ripe for Realization of the Commercial Potential - But Hurdles Still to Overcome has been written to support corporate strategy, new product development, business development, R&D, and brand teams through its analysis of the biologic trends being seen and the innovations taking place in this high growth market place. This report will support the corporate strategies and key decisions being made around emerging market expansion, and future opportunities, and the challenges, which exist.

Key Reasons to Purchase

  • Use this report to understand how the biologics market is expected to develop in the emerging markets and the key growth drivers behind the forecasted changes
  • This report provides an overview of the current biologics landscape in each of the BRIC markets, along with expected challenges and potential areas of growth in the near term
  • Understand how key factors, such as diagnostic testing, high price points and negative perceptions of biologics, are hindering their wider use in some emerging markets
  • Benefit from CBR's in-depth analysis of the competitive landscape for biologics in the BRIC markets, including recent activities of both local and multinational companies and the prospects for collaboration moving forward
  • Access our assessment of how biosimilars are boosting the biologics sector within emerging markets and why they have been so quick to take off in these regions compared to the US and EU market

Key Topics Covered:

Executive summary

Methodology

Biologics overview

  • Definition
  • Different types of biologics
  • The global biologics market

Biologics in emerging markets - key facts

  • Snapshot of key markets
  • Biologics growth prospects
  • Biosimilars and the emerging markets
  • Regulation of biologics
  • BRIC countries in focus

Key challenges to greater use of biologics in the emerging markets

  • Diagnostic testing
  • The high cost of biologics
  • Other hurdles to biologic use

Who are the key biologics players in emerging markets?

  • Overviews of the competitive landscapes and key activities in the BRIC countries

Appendix

  • Supplemental information
  • List of sources

For more information visit http://www.researchandmarkets.com/research/4lrpxl/biologics_in_the

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Read the full story at http://www.prweb.com/releases/2013/2/prweb10454694.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wolters Kluwer Research Now Available via Bloomberg Tradebook
2. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
3. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
4. Researching graphene nanoelectronics for a post-silicon world
5. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
6. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
7. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
8. Multidisciplinary team of researchers develop world’s lightest material
9. K computer research results awarded ACM Gordon Bell Prize
10. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
11. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media ... in 2017 and Beyond. The paper outlines the key trends that are creating ... , “We’ve witnessed a lot of highs and lows as the precision agriculture ...
(Date:5/23/2016)... May 23, 2016 - Leading CRO,s Use ... - Frontage Implement a Single Platform to Manage End-to-end Operations ... Within the Bioanalytical lab Frontage Laboratories, a full-service contract ... and China , has selected IDBS, ... In addition to serving as the global electronic lab notebook (ELN), ...
(Date:5/22/2016)... (PRWEB) , ... May 22, 2016 , ... Doctors in ... in combating the asbestos cancer, malignant mesothelioma. Surviving Mesothelioma has just posted an article ... in the University of Rome’s Department of Clinical Sciences and Translational Medicine evaluated more ...
(Date:5/20/2016)... ... ... Korean researchers say Manumycin A triggers apoptosis, or natural cell death, in ... disease. Surviving Mesothelioma has just posted an article on the new study. Click ... mesothelioma study on the fact the Manumycin A, a derivative of Streptomyces parvulus, is ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):